Objective: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of fatty acids from triglyceride stores in adipocytes. The aim of the present study was to investigate the role of the HSL gene promoter variant C-60G, a polymorphism which previously has been associated with reduced promoter activity in vitro, in obesity and type 2 diabetes. Design: We genotyped two materials consisting of obese subjects and non-obese controls, one material with offspring-parents trios, where the offspring was abdominally obese and one material with trios, where the offspring had type 2 diabetes or impaired glucose homeostasis. HSL promoter containing the HSL C-60G G-allele was generated and tested against a construct with the C-allele in HeLa cells and primary rat adipocytes. HSL mRNA levels were quantified in subcutaneous and visceral fat from 33 obese subjects. Results: We found that the common C-allele was associated with increased waist circumference and WHR in lean controls, but there was no difference in genotype frequency between obese and non-obese subjects. There was a significant increased transmission of C-alleles to the abdominally obese offspring but no increased transmission of C-alleles was observed to offspring with impaired glucose homeostasis. The G-allele showed reduced transcription in HeLa cells and primary rat adipocytes. HSL mRNA levels were significantly higher in subcutaneous compared to visceral fat from obese subjects. Conclusion: The HSL C-60G polymorphism is associated with increased waist circumference in non-obese subjects.
Introduction
Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of fatty acids from the triglyceride stores in adipose tissue. The enzyme is activated by catecholamines through cyclic AMP-dependent phosphorylation, whereas insulin prevents this phosphorylation. 1, 2 The suppression of lipolysis displays insulin resistance in both type 2 diabetes and obesity, resulting in excessive release of free fatty acids (FFA). [3] [4] [5] In addition, several studies have shown that the lipolytic effect of catecholamines is impaired in obese subjects. [6] [7] [8] HSL has been suggested to be responsible for this impaired lipolytic effect, and decreased HSL activity and/or expression have been observed in obese subjects and first-degree relatives of obese subjects. [9] [10] [11] The white adipose tissue (WAT) is a heterogeneous tissue with marked variation in fat metabolism depending on anatomical location. 12 Results concerning the mRNA expression of HSL in visceral and subcutaneous WAT are inconsistent. 13, 14 The human HSL gene consists of nine exons encoding the domains that are common to all known isoforms as well as several upstream exons that are either coding or noncoding and utilized in a tissue-specific manner. 15 It has been mapped to a locus at the long arm of chromosome 19, designated the LIPE locus (19q13. 1-19q13 .2). [16] [17] [18] Several polymorphisms have been described in the HSL gene with evidence of association with obesity phenotypes. [19] [20] [21] [22] [23] [24] Among them an HSL promoter variant, C-60G, of which the G-allele exhibits a 40% reduced promoter activity in vitro, has been identified. 25 Although reduced promoter activity would favor energy storage, the rare G-allele of the HSL C-60G polymorphism has been associated with increased insulin sensitivity in women and lower FFA levels in men, and was therefore suggested to be protective. 26 Here, we investigated the role of HSL C-60G in obesity and type 2 diabetes using case-control and family-based association studies. In addition, we studied the effect of this polymorphism on HSL expression and compared HSL mRNA levels in different adipose depots from obese subjects.
Methods

Study subjects
Clinical characteristics of the study subjects are presented in Table 1 . Two separate case-control studies were performed. The first cohort consisted of 235 obese non-diabetic Swedish subjects (age 42 (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) 29 ), were genotyped to follow transmission of HSL C-60G alleles. In addition, 139 offspring with type 2 diabetes and 156 offspring with either IGT or IFG, according to the WHO criteria from 1998, 29 and their parents (n ¼ 456) were genotyped for HSL C-60G. All trios were selected from the Botnia study. 30 Abdominal visceral and subcutaneous adipose tissues were obtained from 33 of the obese subjects participating in the first case-control study while they were undergoing bariatric surgery at Landskrona Hospital, Sweden (age 36 (31-49) years, BMI 41 (38-44) kg/m 2 ). 31 Biopsies were immediately frozen in liquid nitrogen and stored at À801C until further processing. All subjects gave informed consent and the study was approved by the local ethics committees. Body weight and height were measured with subjects in light clothing without shoes and BMI calculated as weight (kg) divided by height (m) squared. Waist circumference was measured with a soft tape on standing subjects midway between the lowest rib and the iliac crest. Hip circumference was measured over the widest part of the gluteal region, and WHR accordingly calculated, although the measures of both waist and WHR are not very accurate in morbidly obese subjects. Measurements of plasma glucose, serum insulin and plasma lipid concentrations were performed as previously described. 28, 30 
Po0
.0001 compared to obese subjects using Mann-Whitney statistics.
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In vitro luciferase assay Fragments (137 bp) of the exon B promoter with either the C-or G-allele at position -60 were cloned into a pGL3-basic vector (Promega, Madison, WI, USA) and transfected into HeLa cells and primary rat adipocytes. HeLa cells grown in 24-well plates (Costars, Corning Incorporated, NY, USA) were transfected at approximately 80% confluence, with either a pGL3basic vector containing a Firefly luciferace gene, or a pGL3basic containing a Firefly luciferase gene and 137 bp of the region upstream of exon B including the minimal promoter region with either the Cor G-allele at position -60 (1 mg/well). To normalize for the transfection efficiency, a pRL-CMV vector, containing the Renilla luciferase gene, was cotransfected into the cells (100 ng per well). Transfection was performed using 3 ml of FuGene 6 (Roche). The cells were incubated for 24 h.
Isolated adipocytes were prepared by collagenase treatment of epididymal fat pads from male Sprague-Dawley rats (36 days old) (B&K) according to Rodbell. 32 The isolated adipocytes were washed three times in Dulbecco's modified eagle medium (DMEM) and were resuspended in DMEM at a cytocrit of 40%. Vector transfection was performed by electroporation according to Quon. 33 Briefly, 200 ml of cell suspension was transferred to an electroporation cuvette with a 0.4 cm gap (Genetronics), containing an equal volume of PBS with 5 mg pGL3 vector and 250 ng of pRL vector. Electroporation was done using a Gene Pulser transfection apparatus (BioRad) by administering six pulses at 800 V with a capacitance of 25 mF. Following electroporation, cells from 10 cuvettes were pooled into a 60-mm tissue culture dish and were incubated for 16-24 h at 371C with 5% CO 2 .
After the incubation, cells were washed in 10 mM Tris-HCL pH 7.4, 2 mM EDTA, 250 mM sucrose, 20 mg/ml leupeptin, 1 mg/ml antipain, 10 mg/ml pepstatin A and homogenized in passive lysis buffer (Promega) using a glass-teflon homogenizer (10 strokes). A fraction of the cell lysate was subsequently analyzed for Luciferase activity in a Wallac 1420 luminometer (Perkin Elmer) using a Dual-Luciferase Reporter assay kit (Promega). Lysate of uninfected cells was used as blank. For each cell type, two independent experiments were performed in triplicates.
Genotyping DNA was extracted from blood using a conventional method 34 or using DNA Mini Prep (Qiagen, Germany) at the DNA/RNA Genotyping Lab, SWEGENE Resource Center for Profiling Polygenic Disease, Lund University, Malmö University Hospital, Malmö, Sweden. The HSL C-60G was amplified with primers 5 0 -CAG GAC TGG GGC TAG GAC TC-3 0 and 5 0 -GCA GCC TGG GGC AAT AAA CC-3 0 . Polymerase chain reaction was carried out in a 20 ml volume containing 10 mM of each dNTP, 0.3 ml formamide, 0.5 U Taq polymerase (Amersham Pharmacia Biotech, NJ, USA), 5 pmol of each primer and 25 ng genomic DNA. The cycling conditions were 961C for 3 min, 30 cycles of 941C for 30 s, 601C for 30 s and 721C for 30 s, followed by a final extension at 721C for 10 min. Polymerase chain reaction products were digested with 1 U of Rsa I (MBI Fermentas, Hanover, MD, USA) at 371C over night. The digested products were separated on a 3% agarose gel.
Measurement of HSL mRNA using real-time PCR Extraction of total RNA from fat biopsies was performed using the RNeasy Mini kit (Qiagen, Hilden, Germany) and cDNA synthesized using Superscript II RNase H À Reverse
Transcriptase (Life Technologies, MD, USA) and random hexamer primers (Life Technologies). Real-time quantitative PCR was performed using the ABI PRISM 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. Cyclophilin A was used as an endogenous control to standardize the amount of cDNA added to the reactions using a ready to use mix of primers and a VIC labeled probe (Applied Biosystems, Foster City, CA, USA). Primers and probe for HSL mRNA detection were designed using Primer Express Software (Applied Biosystems). Forward primer: 5 0 -GAC TTC CTC CGG GAG TAT GTC A-3 0 , reverse primer: 5 0 -GCG TGA ACT GGA AGC CCA-3 0 and probe: 5 0 -FAM-TGC ATA AGG GAT GCT TCT ATG GCC-TAMRA-3 0 . All samples were run in duplicate and data were calculated using the standard curve method and expressed as a ratio to the Cyclophilin A reference.
Statistical analyses
Descriptive data are presented as median and interquartile range. mRNA data are presented as means7s.e.m. Nonparametric statistical calculations (Wilcoxon, Mann-Whitney and Spearman's statistics) were used except in the comparison of clinical characteristics according to HSL C-60G genotype, where adjustments for relevant variables were performed using the general linear model ( -test was also used to identify significant departures from the Hardy-Weinberg equilibrium. The transmission disequilibrium tests (TDT) were performed using Genhunter 2.1. P-values o0.05 were considered statistically significant. Statistical calculations were performed using NCSS 2000 software (NCSS, Kaysville, Utah, USA).
Results
Case-control association studies There were no significant differences in genotype frequencies between the obese subjects and the controls regarding HSL C-60G neither in the first nor in the second case-control study (Table 2 ). Only two subjects carried the rare HSL C-60G
Hormone-sensitive lipase and obesity E Carlsson et al G/G-genotype, and they were therefore pooled together with the C/G-carriers for further analyses. Non-obese subjects carrying the HSL C-60G G-allele had significantly lower waist circumference (first case-control study, P ¼ 0.01 and second case-control study, P ¼ 0.02) and WHR (second case-control study, P ¼ 0.03) compared to subjects homozygous for the Callele (Table 3) . The difference in waist observed in the first case-control study and the difference in WHR observed in the second case-control study were attenuated after adjusting for age and gender (to P ¼ 0.06 and P ¼ 0.06, respectively, Table 3 ). When all non-obese subjects were included in an ANOVA with age, gender and study center as covariates, waist circumference was significantly lower among controls carrying the HSL C-60G C/G-genotype compared to carriers of the C/C-genotype (P ¼ 0.004). No such difference was observed in the obese subjects (data not shown).
Transmission disequilibrium test (TDT)
Of 296 transmissions, 27 in the TDT with abdominally obese offspring were informative, that is, came from parents heterozygous for the HSL C-60G polymorphism. The HSL C-60G alleles showed a significant deviation from the expected Mendelian 50:50 ratio in the TDT (19 vs 8 transmissions of the C-and G-allele, respectively, P ¼ 0.03).
Out of 64 informative transmissions in the TDT with 295 insulin-resistant offspring, 35 C-alleles were transmitted and 29 not transmitted to the offspring (P ¼ 0.45).
In vitro luciferase assay
The promoter activity of the construct with a G-allele at position -60 was decreased by 32.7% in primary adipocytes (P ¼ 0.04, Figure 1a ) and by 52.5% in HeLa cells (P ¼ 0.002, Figure 1b ) compared to the wild-type construct carrying the C-allele.
HSL mRNA expression in visceral and subcutaneous adipose tissue HSL mRNA levels were reduced in visceral compared to subcutaneous fat obtained from 33 obese subjects (1.0470.08 vs 1.2470.06, P ¼ 0.002, Figure 2 ). Subcutaneous and visceral HSL mRNA levels were weakly correlated to each other (R ¼ 0.34, Po0.05). Subcutaneous HSL mRNA expression was negatively correlated to waist circumference Table 2 Genotype frequencies of HSL C-60G in obese subjects and controls
Genotype
Case-control study 1 Case-control study 2
Obese subjects Controls P Obese subjects Obese subjects Controls Case-control study 2
Obese subjects Controls Data are presented as median (interquartile range). Abbreviations: NA ¼ not applicable, fP ¼ fasting plasma, fS ¼ fasting serum, Tg ¼ triglycerides. After adjusting for age and gender, the difference in waist observed in study 1 and the difference in WHR observed in study 2 were attenuated (to P ¼ 0.06 and P ¼ 0.06), whereas the difference in waist observed in study 2 remained significant (P ¼ 0.03).
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Discussion
In this study we have investigated the role of the HSL C-60G promoter polymorphism in human obesity and impaired glucose homeostasis and related the findings to transcriptional activity in vitro and mRNA levels obtained from adipose tissue biopsies of obese individuals. The HSL C-60G C/C-genotype was associated with increased waist circumference in non-obese but not in obese subjects, and the C-allele was more often transmitted to abdominally obese offspring. No association was seen with impaired glucose homeostasis. We confirmed that the G-allele of the HSL C-60G polymorphism is associated with reduced transcriptional activity in vitro, although no exact conclusion could be drawn in vivo owing to the low number of subjects carrying the G-allele. There was a strong inverse correlation between the mRNA expression in subcutaneous fat and measures of abdominal obesity. To our knowledge, this represents the first case-control study examining the role of the HSL C-60G polymorphism in obesity. A previous study investigating its role in familial combined hyperlipidemia (FCHL) found no association between the polymorphism and FCHL but with increased BMI in women and increased insulin sensitivity in men. 35 HSL C-60G was investigated in 744 healthy young men participating in the second European Atherosclerosis Study, and the G-allele showed association with reduced fasting insulin levels and reduced homeostasis model assessment of insulin resistance (HOMA-IR). 36 Among subjects participating in the HERITAGE Family study, the HSL C-60G G-allele was associated with higher adiposity in black women, while it was associated with a reduced amount of fat in white women. 37 Furthermore, a previous study provided some evidence for a role for HSL in the development in insulin resistance, from which carriers of the HSL C-60G G-allele might be protected. 26 We studied transmission of HSL C-60G alleles from heterozygous parents to offspring with impaired glucose homeostasis, but found no significant Hormone-sensitive lipase and obesity E Carlsson et al deviation from the expected 50:50 Mendelian ratio. In the case-control study, the C-60G G-allele was associated with reduced waist circumference and WHR in the control subjects, but we found no significant differences in genotype frequencies between obese and non-obese subjects. Both waist circumference and WHR are difficult to measure in morbidly obese subjects, and this might explain why we only observed the associations in non-obese subjects. Another explanation is that other stronger genetic factors dominate in persons with morbid obesity. Some caution is also warranted in the interpretation of data as the association was attenuated after adjusting for gender and age in each case-control association study separately.
To confirm the finding of an association between HSL C-60G and waist circumference/WHR we used a family-based approach, that is, studying transmission of the HSL C-60G alleles from heterozygous parents to offspring with a high WHR (WHR 40.85 in women and 40.90 in men but BMI o30 kg/m 2 ). We observed excess transmission of the C-allele to the abdominally obese offspring, (19 vs 8 transmissions, P ¼ 0.03).
A possible explanation for the association between HSL C-60G and waist circumference/WHR might involve effects on gene transcription or enzyme activity. Previous findings in CHO cells indicate that the G-allele has about 40% lower promoter activity compared to the C-allele. 21 In agreement with these results, the C-60G G-allele showed reduced transcription in both HeLa cells and primary rat adipocytes in the present study. However, obese subjects carrying the À60 C/G genotype did not differ significantly from subjects carrying HSL À60 C/C regarding HSL mRNA levels in subcutaneous or visceral adipose tissue. Clearly, this could be due to differences between the in vivo and in vitro conditions per se. Unfortunately, promoter activity has not been measured in human adipocytes avoiding any clear conclusions. In addition, we had only access to adipose tissue from morbidly obese subjects, in whom no effect of the HSL genotypes was seen on measures of abdominal obesity. It has been shown that obese subjects have both reduced HSL expression and activity, 9, 11 and it is possible that this effect overrides that of the promoter polymorphism. Another suggestion is that the size of the sample is too limited to observe a difference in HSL mRNA expression between groups and/or that the presence of two G-alleles (a recessive model) is needed to observe an effect in vivo.
In contrast to the general notion of higher lipolytic responsiveness of visceral compared to subcutaneous adipocytes, HSL mRNA levels were significantly lower in visceral compared to subcutaneous fat. This is in agreement with a previous study observing larger fat cells, lipolysis rates and HSL activity in subcutaneous compared to omental adipose tissue. 13 It was proposed that variation in fat cell size largely explains these differences, as lipolysis rates correlate with fat cell size regardless of adipose region. 13 We believe that our findings of lower levels of HSL mRNA in visceral compared to subcutaneous fat may be indicative of decreased function and therefore a propensity to develop visceral obesity. The mRNA levels of HSL in subcutaneous and visceral adipose tissue in our study were correlated to each other, suggesting that the expression of HSL may be co-regulated in these depots. Even in this obesity-related reduced state of HSL mRNA expression, 38 the expression levels in subcutaneous adipose tissue were negatively correlated to measures of fasting plasma triglyceride levels and abdominal obesity. This suggests that as obesity develops, and perhaps particularly abdominal obesity, HSL expression decreases.
In conclusion, the HSL C-60G polymorphism is associated with increased waist circumference in non-obese subjects, but not with obesity per se nor with insulin resistance or type 2 diabetes. Although the HSL C-60G polymorphism affects transcriptional activity in vitro these findings remain elusive in the in vivo situation.
